Tag
10 articles
LinkedIn co-founder Reid Hoffman has launched an AI drug discovery startup and argues that doctors should routinely seek AI second opinions, calling failure to do so 'bordering on malpractice.'
Isomorphic Labs, a DeepMind spinoff, is advancing AI-designed drugs to human trials, marking a significant milestone in pharmaceutical innovation.
Learn how artificial intelligence is revolutionizing drug discovery by helping researchers identify promising new molecules faster and more efficiently than ever before.
This article explains GPT-Rosalind, OpenAI's new domain-specific AI model for drug discovery and life sciences research, and how it represents a shift toward AI systems that enhance scientific reasoning rather than just automate tasks.
OpenAI introduces GPT-Rosalind, a specialized AI model designed to accelerate drug discovery, genomics analysis, and protein reasoning in life sciences research.
An advanced explainer of OpenAI's GPT-Rosalind, a specialized AI model designed to accelerate drug discovery and genomics research by leveraging advanced biochemistry and genomic analysis capabilities.
Amazon Web Services has launched Amazon Bio Discovery, an AI-powered platform designed to accelerate early-stage drug discovery in the pharmaceutical industry.
AI can now screen 15 million molecules in a day, but it still cannot cure diseases like Alzheimer’s. Despite the hype, real-world applications remain limited.
This article explains how artificial intelligence is revolutionizing biotechnology through machine learning applications in drug discovery and protein engineering, using the recent Anthropic acquisition of Coefficient Bio as a case study.
Dutch biotech Laigo Bio has raised €17 million in seed funding to advance its innovative SureTACs platform, which targets previously 'undruggable' membrane proteins through protein degradation.
